Dried Blood Spot Collection Cards Market Share Grows Steadily at a CAGR of 4%

Introduction

Dried blood spot testing (DBS), a type of bio-sampling, involves blotting and drying blood samples on filter paper. The dried samples can be easily shipped to an analytical facility for analysis utilizing various methods, such as HPLC or DNA amplification. Dried blood spot (DBS) cards are used for blood samples and laboratory examinations for various reasons. These include (i) eliminating the necessity for a phlebotomist with a fingerstick, (ii) enhancing analyte stability at ambient or increased environmental settings, and (iii) simplifying sample transportation without a cold chain.

Dried blood spot collection cards are expected to be impacted by increased testing demand since they support dried blood spot testing. Due to their low cost, dried blood spot collection cards are popular in rural labs and other testing facilities because they allow medical professionals to do multiple tests to ensure accurate results.

Market Dynamics

Growth in the Number of Private-Public Partnerships Drive the Global Market

Government organizations and private-public partnerships will promote diagnostic product use and awareness in the coming years, enhancing market demand. Organizations' newborn testing programs help labs discover novel diagnosis methods to improve screening. The CDC and its partners have run the Newborn Screening Quality Assurance Program for two years. Quality control DBS and proficiency-testing materials for external screening program evaluation help member laboratories evaluate and improve their newborn screening tests. This tool impartially evaluates FDA-approved clinical trial filter paper or collection cards.

PATH, an international nonprofit organization that develops long-term, culturally relevant solutions to help communities with poor health worldwide, offers practical, suitable health technology and vital global health and well-being strategies in collaboration with public-private sector partners. Public-private partnerships and organizational cooperation to develop diagnostic techniques and generate new products will raise market demand over the next few years.

Technological Advancements Creates Tremendous Opportunities

Technological advancements in the blood collection sector have drastically changed how diagnoses and sample collecting are facilitated. Due to the introduction of high-tech products and the release of new products, the global market is expanding. The Ahlstrom GenSaver 2.0 Forensic card, which GenTegra revealed, provides improved security and returns far more DNA than the traditional FTA card. For the market, this will present an opportunity.

Regional Analysis

North America is the most significant global dried blood spot collection cards market shareholder and is estimated to exhibit a CAGR of 3.7% over the forecast period. Growth in the need for diagnostics can be attributed to the rise in the frequency of chronic diseases and the widespread use of technologically improved diagnostic tools. The need for diagnosis and treatment is additionally increased by the region's high prevalence of infectious diseases such as COVID-19, HIV, tuberculosis, and influenza.

Additionally, the region's current healthcare infrastructure and accessibility to government financing for research are further factors projected to boost market expansion. The National Institutes of Health (NIH) promised to invest USD 248.7 million in developing novel technologies in July 2020. Seven biomedical diagnostic businesses received funding from the NIH's Rapid Acceleration of Diagnostics (RADx) initiative to help develop COVID-19 POC and lab-based assays and broaden their accessibility. A favorable environment for business expansion has also been created by increased government efforts and awareness campaigns.

Europe is anticipated to exhibit a CAGR of 3.8% over the forecast period. This market is anticipated to grow as chronic and infectious disease prevalence rises and spending on developing new diagnostics solutions rises. The need for dried blood spot testing for CRO/research applications and therapeutic medication monitoring has also grown in areas with established biotechnology enterprises and research institutes. Due to the COVID-19 pandemic, powerful European nations like Italy, the UK, France, Spain, and Germany experienced a huge increase in demand for diagnostic tools in 2020 to undertake mass testing for the pandemic's containment, including dried blood spot-collecting cards. It's also anticipated that a rise in preterm birth rates and the nation's high risk of perinatal mortality and morbidity will increase demand for its testing services. The widespread use of technologically improved products and ongoing government initiatives to address the rising demand for healthcare are projected to be key drivers of market expansion.

Key Highlights

• The global dried blood spot collection cards market size was valued at USD 296.51 million in 2022. It is estimated to reach USD 422.03 million by 2031, growing at a CAGR of 4% during the forecast period (2023–2031).
• Based on the application, the global dried blood spot collection cards market is bifurcated into Newborn Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, and CRO/Research. The Infectious Diseases Testing segment dominates the global market and is projected to exhibit a CAGR of 4.1% over the forecast period.

• Based on card type, the global dried blood spot collection cards market is bifurcated into Whatman 903, Ahlstrom 226, FTA, and Others. The Whatman 903segment owns the highest market share and is predicted to exhibit a CAGR of 2.6% over the forecast period.
• North America is the most significant global dried blood spot collection cards market shareholder and is estimated to exhibit a CAGR of 3.7% over the forecast period.

Competitive Players

Competitive Players

The key players in the global dried blood spot collection cards market are CENTOGENE, Archimedlife, Shimadzu Corporation, Danaher (Pall Corporation), Qiagen, Perkinelmer, Eastern Business Form, Ahlstrom-Munksjö, and F. Hoffmann-La Roche.

Recent Developments

Market News

• In July 2023- The VERIstic™ is a new small-volume blood collection device by Rhinostics. The VERIstic™ collection device is the first of its kind, combining tried-and-true capillary blood collection with an integrated, automation-ready cap to reduce time, costs, and hassles in a hands-free process when the sample reaches the lab.
• In April 2023- A dried blood spot test was created by a team from Copenhagen University Hospital in Denmark, and it allows for the nucleic acid from each of the three viruses to be detected in a single spot of blood. A single drop of blood could be used in a new test to diagnose HIV, hepatitis B, and C.

Segmentation

Global Dried Blood Spot Collection Cards Market: Segmentation

By Application

• Newborn Screening (NBS)
• Infectious Diseases Testing
• Therapeutic Drug Monitoring
• Forensics
• CRO/Research

By Card Type

• Whatman 903
• Ahlstrom 226
• FTA
• Others

By Regions

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa